FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2619780198> ?p ?o ?g. }

• W2619780198 endingPage "71" @default.
• W2619780198 startingPage "65" @default.
• W2619780198 abstract "Psychophysiological hallmarks of posttraumatic stress disorder (PTSD) include exaggerated fear responses, impaired inhibition and extinction of conditioned fear, and decreased discrimination between safety and fear cues. This increased fear load associated with PTSD can be a barrier to effective therapy thus indicating the need for new treatments to reduce fear expression in people with PTSD. One potential biological target for reducing fear expression in PTSD is the hypothalamic-pituitary-adrenal (HPA) axis, which is dysregulated in PTSD. Recent translational rodent studies and cross-sectional clinical studies have shown that dexamethasone administration and the resulting suppression of cortisol in individuals with PTSD leads to a decrease in the fear responses characteristic of PTSD. These data, taken together, suggest that dexamethasone may serve as a novel pharmacologic intervention for heightened fear responses in PTSD. We conducted a double-blind, placebo-controlled trial to test our hypothesis that dexamethasone administration and the concomitant suppression of HPA axis hyperactivity would attenuate fear expression and enhance fear extinction in individuals with PTSD. Study participants (n = 62) were recruited from Grady Memorial Hospital in Atlanta, GA. Participants were randomized to receive dexamethasone or placebo prior to fear conditioning and extinction, in a counterbalanced design (treatments separated by a week). Both PTSD- (n = 37) and PTSD+ (n = 25) participants showed significant startle increases in the presence of the danger signal during placebo and dexamethasone treatments (all p < 0.05). However, only PTSD- control participants showed decreases in fear-potentiated startle across extinction blocks during both conditions (p’s ≤ 0.001), with PTSD+ participants showing deficits in fear extinction and safety discrimination in the placebo condition. Notably, extinction and discrimination deficits in PTSD+ subjects were markedly reversed with dexamethasone (p < 0.001). These data suggest that dexamethasone may serve as a pharmacological agent with which to facilitate fear extinction and discrimination in individuals with PTSD." @default.
• W2619780198 created "2017-06-05" @default.
• W2619780198 creator A5004215701 @default.
• W2619780198 creator A5016572077 @default.
• W2619780198 creator A5020582941 @default.
• W2619780198 creator A5023826003 @default.
• W2619780198 creator A5025251150 @default.
• W2619780198 creator A5069940824 @default.
• W2619780198 creator A5071537056 @default.
• W2619780198 creator A5076252950 @default.
• W2619780198 creator A5083258080 @default.
• W2619780198 date "2017-09-01" @default.
• W2619780198 modified "2023-09-30" @default.
• W2619780198 title "Dexamethasone facilitates fear extinction and safety discrimination in PTSD: A placebo-controlled, double-blind study" @default.
• W2619780198 cites W1543075896 @default.
• W2619780198 cites W1543244495 @default.
• W2619780198 cites W1566116982 @default.
• W2619780198 cites W1950113474 @default.
• W2619780198 cites W1963722749 @default.
• W2619780198 cites W1969412681 @default.
• W2619780198 cites W1973590159 @default.
• W2619780198 cites W1987716995 @default.
• W2619780198 cites W1990652217 @default.
• W2619780198 cites W1994408961 @default.
• W2619780198 cites W1998030203 @default.
• W2619780198 cites W1998142300 @default.
• W2619780198 cites W2002309367 @default.
• W2619780198 cites W2009780891 @default.
• W2619780198 cites W2015451929 @default.
• W2619780198 cites W2021222178 @default.
• W2619780198 cites W2021393321 @default.
• W2619780198 cites W2023687307 @default.
• W2619780198 cites W2034561886 @default.
• W2619780198 cites W2036194871 @default.
• W2619780198 cites W2046222481 @default.
• W2619780198 cites W2049630090 @default.
• W2619780198 cites W2055107900 @default.
• W2619780198 cites W2060028016 @default.
• W2619780198 cites W2063884007 @default.
• W2619780198 cites W2066563259 @default.
• W2619780198 cites W2066642195 @default.
• W2619780198 cites W2075215563 @default.
• W2619780198 cites W2076246738 @default.
• W2619780198 cites W2079180626 @default.
• W2619780198 cites W2080821873 @default.
• W2619780198 cites W2081273690 @default.
• W2619780198 cites W2088677979 @default.
• W2619780198 cites W2093376597 @default.
• W2619780198 cites W2100900282 @default.
• W2619780198 cites W2101688601 @default.
• W2619780198 cites W2109167188 @default.
• W2619780198 cites W2112374693 @default.
• W2619780198 cites W2122526826 @default.
• W2619780198 cites W2130135754 @default.
• W2619780198 cites W2145918683 @default.
• W2619780198 cites W2154640175 @default.
• W2619780198 cites W2160186948 @default.
• W2619780198 cites W2160848506 @default.
• W2619780198 cites W2162692973 @default.
• W2619780198 cites W2163146990 @default.
• W2619780198 cites W2163655547 @default.
• W2619780198 cites W2163770481 @default.
• W2619780198 cites W2166401337 @default.
• W2619780198 cites W2563944260 @default.
• W2619780198 doi "https://doi.org/10.1016/j.psyneuen.2017.05.023" @default.
• W2619780198 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5524593" @default.
• W2619780198 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28595089" @default.
• W2619780198 hasPublicationYear "2017" @default.
• W2619780198 type Work @default.
• W2619780198 sameAs 2619780198 @default.
• W2619780198 citedByCount "37" @default.
• W2619780198 countsByYear W26197801982018 @default.
• W2619780198 countsByYear W26197801982019 @default.
• W2619780198 countsByYear W26197801982020 @default.
• W2619780198 countsByYear W26197801982021 @default.
• W2619780198 countsByYear W26197801982022 @default.
• W2619780198 countsByYear W26197801982023 @default.
• W2619780198 crossrefType "journal-article" @default.
• W2619780198 hasAuthorship W2619780198A5004215701 @default.
• W2619780198 hasAuthorship W2619780198A5016572077 @default.
• W2619780198 hasAuthorship W2619780198A5020582941 @default.
• W2619780198 hasAuthorship W2619780198A5023826003 @default.
• W2619780198 hasAuthorship W2619780198A5025251150 @default.
• W2619780198 hasAuthorship W2619780198A5069940824 @default.
• W2619780198 hasAuthorship W2619780198A5071537056 @default.
• W2619780198 hasAuthorship W2619780198A5076252950 @default.
• W2619780198 hasAuthorship W2619780198A5083258080 @default.
• W2619780198 hasBestOaLocation W26197801982 @default.
• W2619780198 hasConcept C101991246 @default.
• W2619780198 hasConcept C118552586 @default.
• W2619780198 hasConcept C126322002 @default.
• W2619780198 hasConcept C142724271 @default.
• W2619780198 hasConcept C151730666 @default.
• W2619780198 hasConcept C15744967 @default.
• W2619780198 hasConcept C16837860 @default.
• W2619780198 hasConcept C169760540 @default.
• W2619780198 hasConcept C204787440 @default.
• W2619780198 hasConcept C23332255 @default.

• next